MET and breast carcinoma: Thus, CD151 has been reported to occur as a part of c-Met and β4 or α3/α6 integrin complexes in gastric carcinoma (Franco et al., 2010) or salivary gland and breast cancer cells (Klosek et al., 2005; Klosek et al., 2009), respectively.